Valuation: ResMed, Inc.

Capitalization 28.83B 24.47B 22.41B 21.13B 39.4B 2,747B 39.72B 266B 104B 1,308B 108B 106B 4,527B P/E ratio 2026 *
18.8x
P/E ratio 2027 * 16.9x
Enterprise value 27.92B 23.69B 21.7B 20.46B 38.16B 2,660B 38.46B 257B 100B 1,267B 105B 103B 4,384B EV / Sales 2026 *
4.94x
EV / Sales 2027 * 4.47x
Free-Float
75.61%
Yield 2026 *
1.23%
Yield 2027 * 1.35%
1 day-3.87%
1 week-5.09%
Current month-7.04%
1 month-13.16%
3 months-23.44%
6 months-21.26%
Current year-17.48%
1 week 198.61
Extreme 198.61
213.53
1 month 198.61
Extreme 198.61
232.32
Current year 198.61
Extreme 198.61
277.67
1 year 198.61
Extreme 198.61
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.28
Extreme 56.28
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Change 5d. change 1-year change 3-years change Capi.($)
-3.87%-5.09%-18.89%-15.82% 29.99B
-2.67%-2.16%+12.27%-14.57% 173B
-6.67%-7.14%-21.71%+38.42% 159B
-2.71%-4.32%-12.23%-27.85% 121B
-1.04%-6.12%-48.11%-0.04% 80.16B
-3.49%-7.39%+4.74%-13.08% 46.04B
-0.21%-3.73%-28.67%-37.65% 44.18B
-1.99%+15.30%+1.17%+29.41% 34.86B
-3.60%-0.64%+4.24%-12.69% 32.67B
-0.82%+0.48%-24.46%-44.35% 30.34B
Average -1.98%-0.86%-13.17%-9.82% 75.16B
Weighted average by Cap. -1.70%-2.74%-11.78%-4.32%

Financials

2026 *2027 *
Net sales 5.65B 4.79B 4.39B 4.14B 7.72B 538B 7.78B 52.07B 20.32B 256B 21.2B 20.75B 887B 6.08B 5.16B 4.72B 4.45B 8.31B 579B 8.37B 56.02B 21.87B 276B 22.81B 22.33B 954B
Net income 1.54B 1.31B 1.2B 1.13B 2.11B 147B 2.13B 14.23B 5.55B 70.04B 5.79B 5.67B 242B 1.7B 1.45B 1.32B 1.25B 2.33B 162B 2.35B 15.7B 6.13B 77.32B 6.39B 6.26B 268B
Net Debt -913M -774M -709M -669M -1.25B -86.94B -1.26B -8.41B -3.28B -41.41B -3.42B -3.35B -143B -1.64B -1.4B -1.28B -1.21B -2.25B -157B -2.27B -15.16B -5.92B -74.63B -6.17B -6.04B -258B
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
11/05/26 198.76 $ -3.87% 1,805,472
08/05/26 206.76 $ -0.06% 993,580
07/05/26 206.89 $ -1.31% 1,315,641
06/05/26 209.64 $ +0.85% 1,444,862
05/05/26 207.88 $ -0.74% 1,849,981
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
198.76USD
Average target price
270.60USD
Spread / Average Target
+36.14%

Quarterly revenue - Rate of surprise